相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。3-Acetyl-11-keto-β-boswellic acid attenuated oxidative glutamate toxicity in neuron-like cell lines by apoptosis inhibition
Arezoo Rajabian et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2020)
Acetyl-11-Keto-β-Boswellic Acid Exerts the Anti-Cancer Effects via Cell Cycle Arrest, Apoptosis Induction and Autophagy Suppression in Non-Small Cell Lung Cancer Cells
Minghe Lv et al.
ONCOTARGETS AND THERAPY (2020)
Ironing out the role of the cyclin-dependent kinase inhibitor, p21 in cancer: Novel iron chelating agents to target p21 expression and activity
Rayan S. Moussa et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21
Long Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Synergistic Effect of α-Solanine and Cisplatin Induces Apoptosis and Enhances Cell Cycle Arrest in Human Hepatocellular Carcinoma Cells
Sherien M. El-Daly et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2019)
Knockdown of BRCA2 enhances cisplatin and cisplatin-induced autophagy in ovarian cancer cells
Biao Wan et al.
ENDOCRINE-RELATED CANCER (2018)
PSMD2 regulates breast cancer cell proliferation and cell cycle progression by modulating p21 and p27 proteasomal degradation
Yunhai Li et al.
CANCER LETTERS (2018)
The side effects of platinum-based chemotherapy drugs: a review for chemists
Rabbab Oun et al.
DALTON TRANSACTIONS (2018)
3-O-acetyl-11-keto-beta-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2/M phase
Wan Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Scutellarin Increases Cisplatin-Induced Apoptosis and Autophagy to Overcome Cisplatin Resistance in Non-small Cell Lung Cancer via ERK/p53 and c-met/AKT Signaling Pathways
Chao-Yue Sun et al.
FRONTIERS IN PHARMACOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Acetyl-11-keto-β-boswellic acid ameliorates renal interstitial fibrosis via Klotho/TGF-β/Smad signalling pathway
Minna Liu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Silicon-containing analogs of camptothecin as anticancer agents
Nataliya F. Lazareva et al.
ARCHIV DER PHARMAZIE (2018)
Liquiritin induces apoptosis and autophagy in cisplatin (DDP)-resistant gastric cancer cells in vitro and xenograft nude mice in vivo
Feng Wei et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Nab-Paclitaxel in combination with Cisplatin Versus Docetaxel Plus Cisplatin as First-Line Therapy in Non-small Cell Lung Cancer
Yi Chen et al.
SCIENTIFIC REPORTS (2017)
Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies
Giuseppa Pistritto et al.
AGING-US (2016)
Cisplatin-induced apoptosis in non-small-cell lung cancer cells is dependent on Bax- and Bak-induction pathway and synergistically activated by BH3-mimetic ABT-263 in p53 wild-type and mutant cells
Masaru Matsumoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
DNA damage responsive miR-33b-3p promoted lung cancer cells survival and cisplatin resistance by targeting p21(WAF1/CIP1)
Shun Xu et al.
CELL CYCLE (2016)
P21waf1/ciP1 plays a critical role in furazolidone-induced apoptosis in HepG2 cells through influencing the caspase-3 activation and ROS generation
Sijun Deng et al.
FOOD AND CHEMICAL TOXICOLOGY (2016)
Pharmacological evidences for cytotoxic and antitumor properties of Boswellic acids from Boswellia serrata
Mohammad Ahmed Khan et al.
JOURNAL OF ETHNOPHARMACOLOGY (2016)
Prodrug Strategies for Paclitaxel
Ziyuan Meng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Combination of chrysin and cisplatin promotes the apoptosis of Hep G2 cells by up-regulating p53
Xin Li et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2015)
The role for autophagy in cancer
Eileen White
JOURNAL OF CLINICAL INVESTIGATION (2015)
Hypoxia-induced autophagy mediates cisplatin resistance in lung cancer cells
Hui-Mei Wu et al.
SCIENTIFIC REPORTS (2015)
Non-small-cell lung cancer
Cesare Gridelli et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Biology of the cell cycle inhibitor p21CDKN1A: molecular mechanisms and relevance in chemical toxicology
Ilaria Dutto et al.
ARCHIVES OF TOXICOLOGY (2015)
New Prospects for Vinblastine Analogues as Anticancer Agents
Romano Silvestri
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment
X. Sui et al.
CELL DEATH & DISEASE (2013)
CDK inhibitors (p16/p19/p21) induce senescence and autophagy in cancer-associated fibroblasts, fueling tumor growth via paracrine interactions, without an increase in neo-angiogenesis
Claudia Capparelli et al.
CELL CYCLE (2012)
Boswellic acid inhibits growth and metastasis of human colorectal cancer in orthotopic mouse model by downregulating inflammatory, proliferative, invasive and angiogenic biomarkers
Vivek R. Yadav et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Acetyl-11-keto-β-boswellic acid suppresses invasion of pancreatic cancer cells through the downregulation of CXCR4 chemokine receptor expression
Byoungduck Park et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Cell death-inducing effect of novel palladium(II) and platinum(II) complexes on non-small cell lung cancer cells in vitro
Engin Ulukaya et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
p21WAF1/CIP1 gene transcriptional activation exerts cell growth inhibition and enhances chemosensitivity to cisplatin in lung carcinoma cell
Junxia Wei et al.
BMC CANCER (2010)
Acquired Cisplatin Resistance in Human Lung Adenocarcinoma Cells Is Associated with Enhanced Autophagy
Jing-Hua Ren et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2010)
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial
Tetsuya Mitsudomi et al.
LANCET ONCOLOGY (2010)
Acetyl-11-Keto-β-Boswellic Acid Inhibits Prostate Tumor Growth by Suppressing Vascular Endothelial Growth Factor Receptor 2-Mediated Angiogenesis
Xiufeng Pang et al.
CANCER RESEARCH (2009)
Cisplatin enhances the antitumor effect of tumor necrosis factor-related apoptosis-inducing ligand gene therapy via recruitment of the mitochondria-dependent death signaling pathway
S. Shamimi-Noori et al.
CANCER GENE THERAPY (2008)
Acety-keto-β-boswellic acid induces apoptosis through a death receptor 5-mediated pathway in prostate cancer cells
Min Lu et al.
CANCER RESEARCH (2008)
Autophagy in the pathogenesis of disease
Beth Levine et al.
CELL (2008)
Cisplatin Cytotoxicity: DNA and Plasma Membrane Targets
Amelie Rebillard et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer
Giorgio Vittorio Scagliotti et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Pivotal role of the cyclin-dependent kinase inhibitor p21WAF1/CIP1 in apoptosis and autophagy
Keishi Fujiwara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy
Ken A. Olaussen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Acetyl-11-keto-β-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-κB and NF-κB-regulated gene expression
Yasunari Takada et al.
JOURNAL OF IMMUNOLOGY (2006)
Growth factor regulation of autophagy and cell survival in the absence of apoptosis
JJ Lum et al.
CELL (2005)
Acetyl-boswellic acids inhibit lipopolysaccharide-mediated TNF-alpha induction in monocytes by direct interaction with I kappa B kinases
T Syrovets et al.
JOURNAL OF IMMUNOLOGY (2005)
Cisplatin: mode of cytotoxic action and molecular basis of resistance
ZH Siddik
ONCOGENE (2003)
The BCL2 family: Regulators of the cellular life-or-death switch
S Cory et al.
NATURE REVIEWS CANCER (2002)
Exogenous expression of p21WAF1/CIP1 exerts cell growth inhibition and enhances sensitivity to cisplatin in hepatoma cells
LF Qin et al.
CANCER LETTERS (2001)
Anti-tumor and anti-carcinogenic activities of triterpenoid, beta-boswellic acid
MT Huang et al.
BIOFACTORS (2000)
分享论文
